Organon & Co.
For the period ended Jun 10, 2025. Filed Apr 25, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 10, 2025 · Filed Apr 25, 2025
OGN$13.87+0.6%Stored close · as of Nov 6, 2026
Contents
Overview of Pay Elements
This table identifies and describes the primary elements of the 2024 executive compensation program for our NEOs. The pay elements below are designed to align with our compensation philosophy and objectives, as described below. For a more detailed discussion, see the “Elements of 2024 Compensation Program” section on page 58.
| PayElement | Form and Performance Metric | Objective |
|---|---|---|
| Base Salary | Fixed amount of cash payment | Attract and retain NEOs by offering competitive base salaries based on market practices and each NEO’s position, responsibilities, proficiency and performance |
| AIP | Cash payment which varies based on achievement of: · Constant Current Revenue (40%) · Adjusted EBITDA (40%)· Organizational Health Priorities (20%) | Emphasize and reward the achievement of critical annual financial and strategic objectives |
| LTI | 50% PSUs which vest based on the achievement of: · Three-Year Cumulative Free Cash Flow (50%),· Three-Year Cumulative Constant Currency Revenue (25%) With a Two-Year Cumulative Adjusted EBITDA threshold required for any payout on these two components, and · Three-Year Relative TSR (25%)25% RSUs, the value of which depend on our stock price performance 25% NQSOs, which are only valuable if our stock price increases following the grant date | Motivate and reward the achievement of long-term financial goals and the delivery sustained shareholder valueAlign the interests of our NEOs with shareholders to incentivize the creation of long-term shareholder value |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.